Evidence map›Paper›PMID 33826403›Full record

ArticleAmerican journal of physiology. Gastrointestinal and liver physiology2021

NRG4-ErbB4 signaling represses proinflammatory macrophage activity.

Michael A Schumacher, Isabella C Dennis, Cambrian Y Liu, Cache Robinson, Judie Shang, Jessica K Bernard, M Kay Washington, D Brent Polk, Mark R Frey

Open access · hybridAbstract read
In one paragraph

Article in American journal of physiology. Gastrointestinal and liver physiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Neuregulin 4 in Insulin Resistance: Mechanisms, Controversies, and Therapeutic Perspectives.Diabetes, metabolic syndrome and obesity : targets and therapy · 2026
    Review
  11. Article
  12. Adipocytokine profiles in maternal obesity: The impact of lipoinflammation on serum, breastmilk, and infant metabolic development.Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology · 2025
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Michael A SchumacherThe Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California.
Isabella C DennisThe Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California.
Cambrian Y LiuThe Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California.
Cache RobinsonThe Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California.
Judie ShangThe Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California.
Jessica K BernardThe Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California.
M Kay WashingtonDepartment of Pathology, Microbiology, and Immunology, Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
D Brent PolkThe Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California.
Mark R FreyThe Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California.ORCID 0000-0002-2561-5402
Children's Hospital of Los Angeles · USUniversity of Southern California · USVanderbilt University Medical Center · US

Funding

CYTOKINE REGULATION OF INTESTINAL EPITHELIAL RESTITUTIONR01DK056008 · NIDDK · VANDERBILT UNIVERSITY · PI POLK, D BRENT · 1999 to 2020
$6.8M
The role of the ErbB4 and ErbB3 neuregulin receptors in intestinal epithelial regenerationR01DK095004 · NIDDK · CHILDREN'S HOSPITAL OF LOS ANGELES · PI FREY, MARK R · 2013 to 2022
$3.5M
Stem Cell Dynamics in Colonic Epithelial RepairR01DK108648 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Cambrian Yangshao Liu, D Brent Polk · 2016 to 2026
$2.7M
NIDDK NIH HHS R01 DK056008NIDDK NIH HHS R01 DK095004NIDDK NIH HHS R01 DK108648
6 · The paper itself

Abstract

Proinflammatory macrophages are essential drivers of colitis and express the growth factor receptor ErbB4. This study tested the role of ErbB4 and its specific ligand, NRG4, in regulating macrophage function. We show that endogenous NRG4-ErbB4 signaling limits macrophage production of proinflammatory cytokines in vitro and limits colitis severity in vivo and thus is a potential target for therapeutic intervention.

Indexed as

AnimalsColitisColonCytokinesInflammationInterleukin-10Macrophage ActivationMacrophagesMiceMice, KnockoutNeuregulinsReceptor, ErbB-4Signal TransductionCytokinesErbb4 protein, mouseInterleukin-10neuregulin-4NeuregulinsReceptor, ErbB-4colitiscolonErbB4macrophageNRG4TNF

Identifiers

PMID33826403
PMCPMC8285586
OpenAlexW3144843412

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.